| Year |
Citation |
Score |
| 2023 |
Chen J, Huang CP, Quan C, Zu X, Ou Z, Tsai YC, Messing E, Yeh S, Chang C. The androgen receptor in bladder cancer. Nature Reviews. Urology. PMID 37072491 DOI: 10.1038/s41585-023-00761-y |
0.355 |
|
| 2022 |
Chen D, Chou FJ, Chen Y, Huang CP, Tian H, Wang Y, Niu Y, You B, Yeh S, Xing N, Chang C. Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity. Journal of Experimental & Clinical Cancer Research : Cr. 41: 235. PMID 35918767 DOI: 10.1186/s13046-022-02287-4 |
0.381 |
|
| 2022 |
Yang Y, Sheng J, Hu S, Cui Y, Xiao J, Yu W, Peng J, Han W, He Q, Fan Y, Niu Y, Lin J, Tian Y, Chang C, Yeh S, et al. Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death & Disease. 13: 533. PMID 35672281 DOI: 10.1038/s41419-022-04979-3 |
0.415 |
|
| 2022 |
Ding J, Cui XG, Chen HJ, Sun Y, Yu WW, Luo J, Xiao GQ, Chang C, Qi J, Yeh S. Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma. Cancers. 14. PMID 35406411 DOI: 10.3390/cancers14071639 |
0.317 |
|
| 2021 |
He M, Yang H, Shi H, Hu Y, Chang C, Liu S, Yeh S. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling. Cancer Letters. PMID 34461182 DOI: 10.1016/j.canlet.2021.08.028 |
0.308 |
|
| 2021 |
Deng G, Wang R, Sun Y, Huang CP, Yeh S, You B, Feng C, Li G, Ma S, Chang C. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Cell Death and Differentiation. PMID 34127806 DOI: 10.1038/s41418-021-00743-w |
0.437 |
|
| 2021 |
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C. Corrigendum to: 'New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells'. Journal of Molecular Cell Biology. PMID 33537701 DOI: 10.1093/jmcb/mjaa077 |
0.354 |
|
| 2021 |
You B, Sun Y, Luo J, Wang K, Liu Q, Fang R, Liu B, Chou F, Wang R, Meng J, Huang CP, Yeh S, Chang C, Xu W. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene. PMID 33510354 DOI: 10.1038/s41388-020-01616-1 |
0.422 |
|
| 2021 |
Tian H, Chou FJ, Tian J, Zhang Y, You B, Huang CP, Yeh S, Niu Y, Chang C. ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling. Journal of Experimental & Clinical Cancer Research : Cr. 40: 3. PMID 33390173 DOI: 10.1186/s13046-020-01760-2 |
0.513 |
|
| 2020 |
Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382. PMID 33310747 DOI: 10.1074/jbc.AAC120.016763 |
0.42 |
|
| 2020 |
Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L, Yeh SD, Fujimoto N, Yeh S, Chang C. Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide anti-androgen receptor ASC-J9 lead to promotion suppression of prostate cancer metastasis. The Journal of Biological Chemistry. 295: 15796. PMID 33188084 DOI: 10.1074/jbc.AAC120.016502 |
0.433 |
|
| 2020 |
Chou FJ, Lin C, Tian H, Lin W, You B, Lu J, Sahasrabudhe D, Huang CP, Yang V, Yeh S, Niu Y, Chang C. Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer. Cell Death & Disease. 11: 942. PMID 33139720 DOI: 10.1038/s41419-020-02970-4 |
0.352 |
|
| 2020 |
Lai KP, Yamashita S, Vitkus S, Shyr CR, Yeh S, Chang C. Corrigendum to: "Suppressed Prostate Epithelial Development with Impaired Branching Morphogenesis in Mice Lacking Stromal Fibromuscular Androgen Receptor". Endocrinology. 161. PMID 32966551 DOI: 10.1210/endocr/bqaa148 |
0.441 |
|
| 2020 |
Lin C, Chou FJ, Lu J, Lin W, Truong M, Tian H, Sun Y, Luo J, Yang R, Niu Y, Nadal R, Antonarakis ES, Cordon-Cardo C, Sahasrabudhe D, Huang CP, ... Yeh S, et al. Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells. Aging. 12. PMID 32920545 DOI: 10.18632/aging.103917 |
0.348 |
|
| 2020 |
Altuwaijri S, Chuang KH, Lai KP, Lai JJ, Lin HY, Young FM, Bottaro A, Tsai MY, Zeng WP, Chang HC, Yeh S, Chang C. Corrigendum to: "Susceptibility to Autoimmunity and B Cell Resistance to Apoptosis in Mice Lacking Androgen Receptor in B Cells". Endocrinology. 161. PMID 32822479 DOI: 10.1210/Endocr/Bqaa118 |
0.38 |
|
| 2020 |
Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, Niu Y, Huang ZP, Yeh S, Xing N, Chang C. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Letters. PMID 32768524 DOI: 10.1016/J.Canlet.2020.07.040 |
0.453 |
|
| 2020 |
Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Correction to: Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine. PMID 32617754 DOI: 10.1007/S12020-020-02350-0 |
0.327 |
|
| 2020 |
Liu G, Ouyang X, Sun Y, Xiao Y, You B, Gao Y, Yeh S, Li Y, Chang C. The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling. Cell Death and Differentiation. PMID 32587378 DOI: 10.1038/S41418-020-0575-3 |
0.395 |
|
| 2020 |
Song W, Li L, He D, Xie H, Chen J, Yeh CR, Sien-Shih Chang L, Yeh S, Chang C. Corrigendum to "Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals" [Cancer Lett. 2015 Nov 1 368(1) 71-78]. Cancer Letters. PMID 32487367 DOI: 10.1016/J.Canlet.2020.05.017 |
0.463 |
|
| 2020 |
Wang K, Luo J, Yeh S, You B, Meng J, Chang P, Niu Y, Li G, Lu C, Zhu Y, Antonarakis ES, Luo J, Huang CP, Xu W, Chang C. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nature Communications. 11: 2689. PMID 32483206 DOI: 10.1038/S41467-020-15396-5 |
0.458 |
|
| 2020 |
Gu J, Zhang Y, Han Z, Gao L, Cui J, Sun Y, Niu Y, You B, Huang CP, Chang C, Wang X, Yeh S. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death & Disease. 11: 367. PMID 32409702 DOI: 10.1038/S41419-020-2486-0 |
0.444 |
|
| 2020 |
He M, Yu W, Chang C, Miyamoto H, Liu X, Jiang K, Yeh S. Estrogen receptor α increases lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. Molecular Oncology. PMID 32356397 DOI: 10.1002/1878-0261.12701 |
0.413 |
|
| 2020 |
Chen J, Sun Y, Ou Z, Yeh S, Huang CP, You B, Tsai YC, Sheu TJ, Zu X, Chang C. Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion. Embo Reports. e48467. PMID 32052578 DOI: 10.15252/Embr.201948467 |
0.459 |
|
| 2020 |
Xiao Y, Liu G, Sun Y, Gao Y, Ouyang X, Chang C, Gong L, Yeh S. Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion. Oncogene. PMID 31996784 DOI: 10.1038/S41388-019-1150-6 |
0.336 |
|
| 2020 |
Ding J, Zhang H, Jean J, Chang C, Qi J, Yeh S. PD64-10 ESTROGEN RECEPTOR β PROMOTES RENAL CELL CARCINOMA MALIGNANCY VIA REGULATING LNCRNA HOTAIR AND CIRCULAR RNA-CIRCATP2B1 ASSOCIATED CERNA NETWORK The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000981.010 |
0.312 |
|
| 2020 |
Luo* J, Meng J, Messing EM, Joseph JV, Yeh S, Chang C. MP79-14 LNCRNA-P21 ALTERS THE ANTIANDROGEN ENZALUTAMIDE-INDUCED PROSTATE CANCER NEUROENDOCRINE DIFFERENTIATION VIA MODULATING THE EZH2/STAT3 SIGNALING The Journal of Urology. 203: e1221. DOI: 10.1097/Ju.0000000000000971.014 |
0.473 |
|
| 2020 |
Cui Y, Sun Y, Yang Y, Hu S, Niu Y, Zhang X, Yeh S, Chang C, Jin J. Pd59-03 Hypoxia Induce Neuroendocrine Differentiation Of Prostate Cancer Via Androgen Receptor Related Signals The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000969.03 |
0.48 |
|
| 2020 |
Tao L, Meng J, Messing EM, Joseph JV, Chang C, Qiu J, Yeh S. MP17-19 RECRUITED T CELLS PROMOTE THE BLADDER CANCER METASTASIS VIA UP-REGULATION OF THE ESTROGEN RECEPTOR β/IL-1/C-MET SIGNALS The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000842.020 |
0.388 |
|
| 2019 |
Chen J, Chou F, Yeh S, Ou Z, Shyr C, Huang C, Xiang Z, Sun Y, Messing E, Zu X, Chang C. Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling. Oncogene. PMID 31506605 DOI: 10.1038/S41388-019-0964-6 |
0.474 |
|
| 2019 |
Huang CP, Chen J, Chen CC, Liu G, Zhang Y, Messing E, Yeh S, Chang C. ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals. Journal of Experimental & Clinical Cancer Research : Cr. 38: 275. PMID 31234917 DOI: 10.1186/S13046-019-1258-0 |
0.356 |
|
| 2019 |
Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nature Communications. 10: 2571. PMID 31189930 DOI: 10.1038/S41467-019-09784-9 |
0.478 |
|
| 2019 |
Zhu W, Zhao Z, Chou FJ, Zuo L, Liu T, Bushinsky D, Chang C, Zeng G, Yeh S. The Protective Roles of Estrogen Receptor in Renal Calcium Oxalate Crystal Formation Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury. Oxidative Medicine and Cellular Longevity. 2019: 5305014. PMID 31178964 DOI: 10.1155/2019/5305014 |
0.315 |
|
| 2019 |
Zhu W, Zhao Z, Chou F, Zuo L, Liu T, Yeh S, Bushinsky D, Zeng G, Chang C. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals. Cell Death & Disease. 10: 275. PMID 30894518 DOI: 10.1097/Ju.0000000000000830.05 |
0.326 |
|
| 2019 |
Chou FJ, Chen Y, Chen D, Niu Y, Li G, Keng P, Yeh S, Chang C. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression. Ebiomedicine. PMID 30692044 DOI: 10.1016/J.Ebiom.2018.12.050 |
0.551 |
|
| 2019 |
Wang R, Chang C, Yeh S. Mp68-17 Enzalutamide-Induced Antiandrogen-Resistance Via A Unique Trans-Splicing Mechanism To Induce A Novel Androgen Receptor Mutant Arv33 The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557032.17578.89 |
0.376 |
|
| 2019 |
Han Z, Xu H, Chou F, Sun Y, Chen J, Zhang Y, Wang X, Chang C, Messing EM, Yeh S. MP16-14 ERβ-MEDIATED ALTERATION OF CIRCATP2B1 AND MIR-204-3P SIGNALING PROMOTES INVASION OF CLEAR CELL RENAL CELL CARCINOMA The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555350.06182.00 |
0.351 |
|
| 2019 |
Song W, Xu* H, Doersch KM, Chou F, He D, Chen Y, Hsu I, Yeh C, Chang LS, Li L, Messing E, Chang C, Yeh S. MP16-04 TARGETING NEWLY IDENTIFIED ERβ/TGF-β1/SMAD3 SIGNALS WITH THE FDA-APPROVED ANTI-ESTROGEN FASLODEX OR AN ERβ SELECTIVE ANTAGONIST IN RENAL CELL CARCINOMA Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555340.89148.9F |
0.312 |
|
| 2018 |
Ou Z, Wang Y, Chen J, Tao L, Zuo L, Sahasrabudhe D, Joseph J, Wang L, Yeh S. Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals. Experimental & Molecular Medicine. 50: 152. PMID 30459405 DOI: 10.1038/S12276-018-0155-5 |
0.357 |
|
| 2018 |
Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in the altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype. Cancer Letters. PMID 30448543 DOI: 10.1016/J.Canlet.2018.11.004 |
0.358 |
|
| 2018 |
Yu W, Ding J, He M, Chen Y, Wang R, Han Z, Xing EZ, Zhang C, Yeh S. Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer. Oncogene. PMID 30250297 DOI: 10.1038/S41388-018-0463-1 |
0.388 |
|
| 2018 |
Luo J, Tian J, Chou F, Lin C, Xing EZ, Zuo L, Niu Y, Yeh S, Chang C. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9 led to increase docetaxel sensitivity via suppressing the p21 expression. Cancer Letters. PMID 30248372 DOI: 10.1016/J.Canlet.2018.09.025 |
0.509 |
|
| 2018 |
Niu Y, Guo C, Wen S, Tian J, Luo J, Wang K, Tian H, Yeh S, Chang C. ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis. Cancer Letters. PMID 30227222 DOI: 10.1016/J.Canlet.2018.09.020 |
0.551 |
|
| 2018 |
Song W, He D, Chen Y, Yeh CR, Hsu I, Huang Q, Zhang X, Chang LS, Zuo L, Chen J, Doersch KM, Chang C, Yeh S. Targeting newly identified ERβ/TGFβ-1/SMAD3 signals with the FDA-approved antiestrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma. Molecular Oncology. PMID 30171816 DOI: 10.1002/1878-0261.12377 |
0.415 |
|
| 2018 |
Bai J, Yeh S, Qiu X, Hu L, Zeng J, Cai Y, Zuo L, Li G, Yang G, Chang C. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals. Oncogene. PMID 29973687 DOI: 10.1038/S41388-018-0269-1 |
0.4 |
|
| 2018 |
Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou Z, Chang C, Qi J, Yeh S. Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene. PMID 29789714 DOI: 10.1038/S41388-018-0175-6 |
0.377 |
|
| 2018 |
Kao TL, Kuan YP, Cheng WC, Chang WC, Jeng LB, Yeh S, Ma WL. Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration. Theranostics. 8: 2672-2682. PMID 29774067 DOI: 10.7150/Thno.23624 |
0.356 |
|
| 2018 |
Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, Guancial EA, Messing EM, Chang C, Yeh S. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals. Cancer Letters. PMID 29684419 DOI: 10.1016/J.Canlet.2018.03.045 |
0.401 |
|
| 2018 |
Han Z, Zhang Y, Sun Y, Chen J, Chang C, Wang X, Yeh S. ERβ-mediated alteration of circATP2B1 and miR-204-3p signaling promotes invasion of clear cell renal cell carcinoma. Cancer Research. PMID 29490945 DOI: 10.1158/0008-5472.Can-17-1575 |
0.371 |
|
| 2018 |
Ding J, Chen J, Yeh CR, Yin S, Lin C, Chou J, Ou Z, Chang C, Messing EM, Qi J, Yeh S. MP88-10 ESTROGEN RECEPTOR β PROMOTES RENAL CELL CARCINOMA PROGRESSION VIA REGULATING LNCRNA HOTAIR-MIR-138/200C/204/217 ASSOCIATED CERNA NETWORK Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2930 |
0.344 |
|
| 2018 |
Bai J, Chen J, Qiu X, Yeh S, Hu L, Zeng J, Cai Y, Li G, Messing EM, Yang G, Chang C. MP88-08 TR4 NUCLEAR RECEPTOR PROMOTES CLEAR CELL RENAL CELL CARCINOMA (CCRCC) VASCULOGENIC MIMICRY (VM) FORMATION AND METASTASIS VIA ALTERING THE MIR490-3P/VIMENTIN SIGNALS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2928 |
0.364 |
|
| 2018 |
Yang Y, Shen J, Jin S, Xiang P, Fan Y, Lv T, He Q, Yu W, Hu S, Chang C, Yeh S, Jin J. MP45-02 INCREASED STROMAL COMPONENTS AND PROSTATIC FIBROSIS VIA ALTERING THE CYP19/ESTROGEN/GPER SIGNALING IN THE EARLY PROGRESSION OF BPH TISSUES OF MEN ≤ 50 YEARS OLD Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1441 |
0.449 |
|
| 2017 |
Kao TL, Chen YL, Kuan YP, Chang WC, Ho YC, Yeh S, Jeng LB, Ma WL. Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression. Cell Transplantation. 26: 1822-1829. PMID 29338386 DOI: 10.1177/0963689717738258 |
0.314 |
|
| 2017 |
Cheng MA, Chou FJ, Wang K, Yang R, Ding J, Zhang Q, Li G, Yeh S, Xu D, Chang C. Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. Cancer Letters. PMID 29203251 DOI: 10.1016/J.Canlet.2017.11.038 |
0.567 |
|
| 2017 |
Chen J, Li L, Yang Z, Luo J, Yeh S, Chang C. Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression. Cancer Letters. PMID 28826721 DOI: 10.1016/J.Canlet.2017.08.014 |
0.559 |
|
| 2017 |
Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, Antonarakis ES, Luo J, Yeh S, Chang C. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression. European Urology. PMID 28528814 DOI: 10.1016/J.Eururo.2017.04.005 |
0.532 |
|
| 2017 |
Lin SJ, Chou FJ, Li L, Lin CY, Yeh S, Chang C. Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7). Cancer Letters. PMID 28373004 DOI: 10.1016/J.Canlet.2017.03.035 |
0.541 |
|
| 2017 |
Guo C, Yeh S, Niu Y, Li G, Zheng J, Li L, Chang C. Targeting Androgen Receptor versus Targeting Androgens to suppress Castration Resistant Prostate Cancer. Cancer Letters. PMID 28323036 DOI: 10.1016/J.Canlet.2017.03.022 |
0.541 |
|
| 2017 |
Yang Y, Yeh C, Slavin S, Luo J, Chou F, Wang K, Truong M, Chang C, Messing EM, Yeh S. MP87-13 ESTROGEN RECEPTOR α IN CANCER ASSOCIATED FIBROBLASTS SUPPRESSES PROSTATE CANCER INVASION VIA REDUCING CCL5, IL6 AND MACROPHAGE INFILTRATION IN THE TUMOR MICROENVIRONMENT. Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2717 |
0.475 |
|
| 2017 |
Shang Z, Yang Y, Truong M, Li Y, Hsu I, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. MP65-12 TARGETING ESTROGEN/ESTROGEN RECEPTOR SIGNAL PATHWAYS TO ENHANCE THE EFFICACY OF BACILLUS CALMETTE-GUÉRIN TREATMENT IN BLADDER CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2006 |
0.407 |
|
| 2016 |
Xie H, Li L, Zhu G, Dang Q, Ma Z, He D, Chang L, Song W, Chang HC, Krolewski JJ, Nastiuk KL, Yeh S, Chang C. Correction: Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals. Oncotarget. 7: 83829-83830. PMID 28082729 DOI: 10.18632/oncotarget.13913 |
0.374 |
|
| 2016 |
Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 7: 83828. PMID 28082728 DOI: 10.18632/oncotarget.13912 |
0.451 |
|
| 2016 |
Wang Y, Ou Z, Sun Y, Yeh S, Wang X, Long J, Chang C. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals. Oncogene. PMID 27869170 DOI: 10.1038/Onc.2016.330 |
0.425 |
|
| 2016 |
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C. Corrigendum to "Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling" [Mol Oncol 9 (1) (2015) 44-57]. Molecular Oncology. PMID 27838215 DOI: 10.1016/J.Molonc.2016.10.005 |
0.554 |
|
| 2016 |
Lin SJ, Chou FJ, Lin CY, Chang HC, Yeh S, Chang C. New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals. Oncotarget. PMID 27564257 DOI: 10.18632/Oncotarget.11484 |
0.471 |
|
| 2016 |
Cui Y, Sun Y, Hu S, Luo J, Li L, Li X, Yeh S, Jin J, Chang C. Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals. Oncogene. PMID 27375022 DOI: 10.1038/Onc.2016.135 |
0.56 |
|
| 2016 |
Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H, Zang L, Xia S, Chang C. Infiltrated T cells promote bladder cancer progression via increasing IL-1→androgen receptor (AR)→HIF-1α→VEGFa signals. Molecular Cancer Therapeutics. PMID 27196763 DOI: 10.1158/1535-7163.Mct-15-0306 |
0.39 |
|
| 2016 |
Shang Z, Li Y, Hsu I, Zhang M, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. Targeting estrogen/estrogen receptor alpha will enhance Bacillus Calmette-Guerin efficacy in bladder cancer. Oncotarget. PMID 27092883 DOI: 10.18632/Oncotarget.8756 |
0.446 |
|
| 2016 |
Wen S, Tian J, Niu Y, Li L, Yeh S, Chang C. ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals. Cancer Letters. PMID 27045473 DOI: 10.1016/J.Canlet.2016.01.057 |
0.51 |
|
| 2016 |
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C. Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib Plus NK Cells-Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. PMID 26939703 DOI: 10.1158/1535-7163.Mct-15-0706 |
0.422 |
|
| 2016 |
Wen S, Niu Y, Lee SO, Yeh S, Shang Z, Gao H, Li Y, Chou F, Chang C. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells. Molecular Carcinogenesis. PMID 26894509 DOI: 10.1002/Mc.22468 |
0.575 |
|
| 2016 |
Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Yeh S, Cai X, Chang C. Cisplatin enhances NK cell immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Cancer Letters. PMID 26805759 DOI: 10.1016/J.Canlet.2016.01.017 |
0.426 |
|
| 2016 |
Yeh CR, Slavin S, Da J, Hsu I, Luo J, Xiao GQ, Ding J, Chou FJ, Yeh S. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment. Molecular Cancer. 15: 7. PMID 26790618 DOI: 10.1186/S12943-015-0488-9 |
0.556 |
|
| 2015 |
Wang X, Ring BZ, Seitz RS, Ross DT, Woolf K, Beck RA, Hicks DG, Yeh S. Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients. Bmc Clinical Pathology. 15: 21. PMID 26664297 DOI: 10.1186/S12907-015-0021-5 |
0.31 |
|
| 2015 |
Yeh CR, Ou ZY, Xiao GQ, Guancial E, Yeh S. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals. Oncotarget. PMID 26587829 DOI: 10.18632/Oncotarget.5884 |
0.376 |
|
| 2015 |
Rao Q, Chen Y, Yeh CR, Jie D, Li L, Chang C, Yeh S. Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals. Oncotarget. PMID 26556868 DOI: 10.18632/Oncotarget.5467 |
0.421 |
|
| 2015 |
Lin C, Lin W, Yeh S, Li L, Chang C. Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals. Oncotarget. PMID 26517808 DOI: 10.18632/Oncotarget.5638 |
0.498 |
|
| 2015 |
Singh S, Pan C, Wood R, Yeh CR, Yeh S, Sha K, Krolewski JJ, Nastiuk KL. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound. Bmc Urology. 15: 97. PMID 26391476 DOI: 10.1186/S12894-015-0091-9 |
0.447 |
|
| 2015 |
Sha K, Yeh S, Chang C, Nastiuk KL, Krolewski JJ. TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures. Oncotarget. 6: 25726-40. PMID 26327448 DOI: 10.18632/Oncotarget.4535 |
0.517 |
|
| 2015 |
Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, Chang C. Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals. Oncotarget. 6: 26065-78. PMID 26305549 DOI: 10.18632/Oncotarget.4569 |
0.423 |
|
| 2015 |
Shang Z, Li Y, Zhang M, Tian J, Han R, Shyr CR, Messing E, Yeh S, Niu Y, Chang C. Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9® enhances BCG efficacy to better suppress bladder cancer progression. Molecular Cancer Therapeutics. PMID 26264279 DOI: 10.1158/1535-7163.Mct-14-1055-T |
0.448 |
|
| 2015 |
Song W, Li L, He D, Xie H, Chen J, Yeh CR, Chang LS, Yeh S, Chang C. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR)→c-Myc signals. Cancer Letters. PMID 26231735 DOI: 10.1016/J.Canlet.2015.07.027 |
0.449 |
|
| 2015 |
Wen S, Niu Y, Yeh S, Chang C. BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts. International Journal of Oncology. PMID 26095189 DOI: 10.3892/Ijo.2015.3060 |
0.494 |
|
| 2015 |
Song W, Yeh CR, He D, Wang Y, Xie H, Pang ST, Chang LS, Li L, Yeh S. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals. Oncotarget. PMID 26079540 DOI: 10.18632/Oncotarget.4478 |
0.397 |
|
| 2015 |
Wang RS, Chang HY, Kao SH, Kao CH, Wu YC, Yeh S, Tzeng CR, Chang C. Abnormal mitochondrial function and impaired granulosa cell differentiation in androgen receptor knockout mice. International Journal of Molecular Sciences. 16: 9831-49. PMID 25941928 DOI: 10.3390/Ijms16059831 |
0.413 |
|
| 2015 |
Xie H, Li L, Zhu G, Dang Q, Ma Z, He D, Chang L, Song W, Chang HC, Krolewski JJ, Nastiuk KL, Yeh S, Chang C. Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals. Oncotarget. 6: 12326-39. PMID 25940439 DOI: 10.18632/Oncotarget.3619 |
0.537 |
|
| 2015 |
Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 6: 14179-90. PMID 25895025 DOI: 10.18632/Oncotarget.3651 |
0.545 |
|
| 2015 |
Dang Q, Li L, Xie H, He D, Chen J, Song W, Chang LS, Chang HC, Yeh S, Chang C. Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals. Molecular Oncology. PMID 25817444 DOI: 10.1016/J.Molonc.2015.02.010 |
0.528 |
|
| 2015 |
Chen YH, Chen CJ, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Tsai KS, Wu SY, Chang C, Chen HY, Yeh S. Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence. World Journal of Urology. PMID 25577129 DOI: 10.1007/S00345-014-1474-3 |
0.351 |
|
| 2015 |
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling. Molecular Oncology. 9: 44-57. PMID 25135278 DOI: 10.1016/J.Molonc.2014.07.013 |
0.509 |
|
| 2015 |
Yeh C, Hsu I, Miyamoto H, Wu X, Chang C, Guancial E, Messing EM, Yeh S. Mp68-13 Estrogen Receptor Alpha Prevents Bladder Cancer Via Inpp4B Inhibited Akt Pathway In Vitro And In Vivo The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2475 |
0.398 |
|
| 2015 |
Hu S, Cui Y, Li X, Yeh S, Jin J, Guo Y, Chang C. Mp37-03 Infiltrating Neutrophils Promote Prostate Cancer Proliferation Via Alteration Of Il8-Androgen Receptor Signaling The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1266 |
0.508 |
|
| 2014 |
Yeh CR, Da J, Song W, Fazili A, Yeh S. Estrogen receptors in prostate development and cancer. American Journal of Clinical and Experimental Urology. 2: 161-8. PMID 25374919 |
0.464 |
|
| 2014 |
Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. Oncotarget. 5: 7917-35. PMID 25277204 DOI: 10.18632/Oncotarget.1421 |
0.467 |
|
| 2014 |
Chen YH, Chen CJ, Yeh S, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Chang C, Chen HY. Urethral dysfunction in female mice with estrogen receptor β deficiency. Plos One. 9: e109058. PMID 25275480 DOI: 10.1371/Journal.Pone.0109058 |
0.352 |
|
| 2014 |
Yu IC, Lin HY, Sparks JD, Yeh S, Chang C. Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome. Diabetes. 63: 3180-8. PMID 25249645 DOI: 10.2337/Db13-1505 |
0.475 |
|
| 2014 |
Xu D, Lin TH, Yeh CR, Cheng MA, Chen LM, Chang C, Yeh S. The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth. Biomed Research International. 2014: 713263. PMID 25221777 DOI: 10.1155/2014/713263 |
0.4 |
|
| 2014 |
Wu S, Chen Y, Fajobi T, DiVall SA, Chang C, Yeh S, Wolfe A. Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice. Molecular Endocrinology (Baltimore, Md.). 28: 1670-81. PMID 25157703 DOI: 10.1210/Me.2014-1154 |
0.389 |
|
| 2014 |
Liang L, Li L, Tian J, Lee SO, Dang Q, Huang CK, Yeh S, Erturk E, Bushinsky D, Chang LS, He D, Chang C. Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress. Molecular Endocrinology (Baltimore, Md.). 28: 1291-303. PMID 24956378 DOI: 10.1210/Me.2014-1047 |
0.385 |
|
| 2014 |
He D, Li L, Zhu G, Liang L, Guan Z, Chang L, Chen Y, Yeh S, Chang C. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway. Cancer Research. 74: 4420-30. PMID 24924778 DOI: 10.1158/0008-5472.Can-13-2681 |
0.455 |
|
| 2014 |
Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer. 21: R165-82. PMID 24424503 DOI: 10.1530/Erc-13-0283 |
0.405 |
|
| 2014 |
Slavin S, Yeh CR, Da J, Yu S, Miyamoto H, Messing EM, Guancial E, Yeh S. Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3. Carcinogenesis. 35: 1301-9. PMID 24374826 DOI: 10.1093/Carcin/Bgt488 |
0.479 |
|
| 2014 |
Zhu G, Liang L, Li L, Dang Q, Song W, Yeh S, He D, Chang C. The expression and evaluation of androgen receptor in human renal cell carcinoma. Urology. 83: 510.e19-24. PMID 24332122 DOI: 10.1016/J.Urology.2013.10.022 |
0.441 |
|
| 2014 |
Hsu I, Chuang KL, Slavin S, Da J, Lim WX, Pang ST, O'Brien JH, Yeh S. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development. Carcinogenesis. 35: 651-61. PMID 24148819 DOI: 10.1093/Carcin/Bgt348 |
0.458 |
|
| 2014 |
Shang Z, Niu Y, Cai Q, Chen J, Tian J, Yeh S, Lai KP, Chang C. Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1881-90. PMID 24122203 DOI: 10.1007/S13277-013-1253-6 |
0.546 |
|
| 2014 |
Soh SF, Huang CK, Lee SO, Xu D, Yeh S, Li J, Yong EL, Gong Y, Chang C. Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 88: 117-22. PMID 24042123 DOI: 10.1016/J.Jpba.2013.08.020 |
0.389 |
|
| 2014 |
Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 33: 3225-34. PMID 23873027 DOI: 10.1038/Onc.2013.274 |
0.535 |
|
| 2014 |
He D, Li L, Zhu G, Liang L, Guan Z, Chang L, Chen Y, Yeh S, Chang C. AB130. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway. Translational Andrology and Urology. 3: 130. DOI: 10.3978/J.Issn.2223-4683.2014.S130 |
0.466 |
|
| 2014 |
Song W, Li L, Messing E, He D, Yeh S, Chang C. MP29-20 ERβ CAN PROMOTE RENAL CELL CARCINOMA PROGRESSION VIA TGFβ-1/SMAD3 PATHWAY Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.762 |
0.305 |
|
| 2014 |
Yeh C, Slavin S, Da J, Chang C, Messing EM, Miyamoto H, Yeh S. MP52-13 ESTROGEN RECEPTOR α IN CANCER ASSOCIATED FIBROBLASTS SUPPRESSES PROSTATE CANCER INVASION VIA MODULATION OF THROMBOSPONDIN-2 AND MATRIX METALLOPROTEINASE 3 Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1623 |
0.498 |
|
| 2014 |
Yeh C, Hsu I, Slavin S, Chang C, Messing EM, Miyamoto H, Yeh S. MP34-02 ESTROGEN RECEPTOR ALPHA PREVENTS BLADDER CANCER VIA INPP4B/AKT PATHWAY: IN VIVO KNOCKOUT MOUSE EVIDENCE AND HUMAN TISSUE ANALYSIS Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1015 |
0.385 |
|
| 2013 |
Chang C, Yeh S, Lee SO, Chang TM. Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells. Nuclear Receptor Signaling. 11: e001. PMID 24653668 DOI: 10.1621/Nrs.11001 |
0.462 |
|
| 2013 |
Yu S, Xia S, Yang D, Wang K, Yeh S, Gao Z, Chang C. Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion. Medical Oncology (Northwood, London, England). 30: 674. PMID 23925662 DOI: 10.1007/S12032-013-0674-9 |
0.571 |
|
| 2013 |
Lai KP, Huang CK, Fang LY, Izumi K, Lo CW, Wood R, Kindblom J, Yeh S, Chang C. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH). Molecular Endocrinology (Baltimore, Md.). 27: 1617-31. PMID 23893956 DOI: 10.1210/Me.2013-1207 |
0.575 |
|
| 2013 |
Chang C, Lee SO, Wang RS, Yeh S, Chang TM. Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells. Biology of Reproduction. 89: 21. PMID 23782840 DOI: 10.1095/Biolreprod.113.109132 |
0.435 |
|
| 2013 |
Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L, Yeh SD, Fujimoto N, Yeh S, Chang C. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis. The Journal of Biological Chemistry. 288: 19359-69. PMID 23687298 DOI: 10.1074/Jbc.M113.477216 |
0.52 |
|
| 2013 |
Hsu I, Vitkus S, Da J, Yeh S. Role of oestrogen receptors in bladder cancer development. Nature Reviews. Urology. 10: 317-26. PMID 23588401 DOI: 10.1038/Nrurol.2013.53 |
0.445 |
|
| 2013 |
Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li L, Yeh S, Chang C. Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals. Molecular Cancer Therapeutics. 12: 1026-37. PMID 23536722 DOI: 10.1158/1535-7163.Mct-12-0895 |
0.536 |
|
| 2013 |
Lai KP, Lai JJ, Chang P, Altuwaijri S, Hsu JW, Chuang KH, Shyr CR, Yeh S, Chang C. Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy. Molecular Endocrinology (Baltimore, Md.). 27: 25-37. PMID 23250486 DOI: 10.1210/Me.2012-1244 |
0.438 |
|
| 2013 |
Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S, Chang C. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. The American Journal of Pathology. 182: 460-73. PMID 23219429 DOI: 10.1016/J.Ajpath.2012.10.029 |
0.581 |
|
| 2013 |
Vitkus S, Yeh CR, Lin HH, Hsu I, Yu J, Chen M, Yeh S. Distinct function of estrogen receptor α in smooth muscle and fibroblast cells in prostate development. Molecular Endocrinology (Baltimore, Md.). 27: 38-49. PMID 23204329 DOI: 10.1210/Me.2012-1212 |
0.53 |
|
| 2013 |
Yu IC, Lin HY, Liu NC, Sparks JD, Yeh S, Fang LY, Chen L, Chang C. Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression. Diabetes. 62: 411-23. PMID 23139353 DOI: 10.2337/Db12-0135 |
0.409 |
|
| 2013 |
Zhu B, Li X, Zhang Y, Ye C, Wang Y, Cai S, Huang H, Cai Y, Yeh S, Huang Z, Chen R, Tao Y, Wen X. Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 132: 2270-82. PMID 23129185 DOI: 10.1002/ijc.27927 |
0.371 |
|
| 2013 |
Li L, Xie H, Liang L, Gao Y, Zhang D, Fang L, Lee SO, Luo J, Chen X, Wang X, Chang LS, Yeh S, Wang Y, He D, Chang C. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage. Carcinogenesis. 34: 257-67. PMID 23104178 DOI: 10.1093/Carcin/Bgs337 |
0.541 |
|
| 2013 |
Shyr CR, Chen CC, Hsieh TF, Chang CH, Ma WL, Yeh S, Messing E, Li TH, Li FY, Chang C. The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells. Endocrine. 43: 191-9. PMID 22851332 DOI: 10.1007/S12020-012-9762-4 |
0.472 |
|
| 2013 |
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C. New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. Journal of Molecular Cell Biology. 5: 14-26. PMID 22831834 DOI: 10.1093/Jmcb/Mjs042 |
0.429 |
|
| 2013 |
Vitkus S, Yeh C, Lin H, Hsu I, Yu J, Chen M, Yeh S. 1610 THE DISTINCT FUNCTION OF ESTROGEN RECEPTOR α IN SMOOTH MUSCLE AND FIBROBLAST CELLS The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.3160 |
0.349 |
|
| 2013 |
liang l, li l, tian j, lee SO, dang Q, huang C, yeh S, chang LS, he d, chang C. 2300 ORGAN SPECIFIC ANDROGEN RECEPTOR KNOCKOUT MICE SUPPRESS BIOSYNTHESIZE OF OXALATE AND OXIDATIVE INJURY OF KIDNEY EPITHELIAL CELL ON THE PROCESS OF OXALATE CRYSTAL RETENTION Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2241 |
0.352 |
|
| 2012 |
Jiang Q, Yeh S, Wang X, Xu D, Zhang Q, Wen X, Xia S, Chang C. Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy. The Journal of Urology. 188: 1361-8. PMID 22906664 DOI: 10.1016/J.Juro.2012.06.004 |
0.582 |
|
| 2012 |
Lai KP, Yamashita S, Huang CK, Yeh S, Chang C. Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. Embo Molecular Medicine. 4: 791-807. PMID 22745041 DOI: 10.1002/Emmm.201101140 |
0.573 |
|
| 2012 |
Chen M, Yeh CR, Shyr CR, Lin HH, Da J, Yeh S. Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout mice. Asian Journal of Andrology. 14: 546-55. PMID 22609821 DOI: 10.1038/Aja.2011.181 |
0.526 |
|
| 2012 |
Lee SO, Tian J, Huang CK, Ma Z, Lai KP, Hsiao H, Jiang M, Yeh S, Chang C. Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells. The Journal of Endocrinology. 213: 173-82. PMID 22393245 DOI: 10.1530/Joe-11-0474 |
0.551 |
|
| 2012 |
Yamashita S, Lai KP, Chuang KL, Xu D, Miyamoto H, Tochigi T, Pang ST, Li L, Arai Y, Kung HJ, Yeh S, Chang C. ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. Neoplasia (New York, N.Y.). 14: 74-83. PMID 22355276 DOI: 10.1593/Neo.111436 |
0.553 |
|
| 2012 |
Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology (Baltimore, Md.). 56: 176-85. PMID 22318717 DOI: 10.1002/Hep.25644 |
0.405 |
|
| 2012 |
Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. Bju International. 109: 1716-26. PMID 22221549 DOI: 10.1016/J.Juro.2012.02.453 |
0.408 |
|
| 2012 |
Xu D, Lin TH, Li S, Da J, Wen XQ, Ding J, Chang C, Yeh S. Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. Cancer Letters. 316: 11-22. PMID 22154085 DOI: 10.1016/J.Canlet.2011.10.006 |
0.55 |
|
| 2012 |
Lai KP, Yamashita S, Vitkus S, Shyr CR, Yeh S, Chang C. Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Molecular Endocrinology (Baltimore, Md.). 26: 52-66. PMID 22135068 DOI: 10.1210/Me.2011-1189 |
0.531 |
|
| 2012 |
Chen M, Yeh CR, Chang HC, Vitkus S, Wen XQ, Bhowmick NA, Wolfe A, Yeh S. Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models. The Journal of Pathology. 226: 17-27. PMID 22069040 DOI: 10.1002/Path.2949 |
0.542 |
|
| 2012 |
Xu D, Lin TH, Zhang C, Tsai YC, Li S, Zhang J, Yin M, Yeh S, Chang C. The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells. The Prostate. 72: 803-16. PMID 21932429 DOI: 10.1002/Pros.21474 |
0.563 |
|
| 2012 |
Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, Shyr CR, Chang C, Yeh S. Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. The Prostate. 72: 437-49. PMID 21739465 DOI: 10.1002/Pros.21445 |
0.558 |
|
| 2012 |
Ideta R, Yeh S, Lee Y, Adachi K, Takeda H, Su C, Saltzman A, Chang C. Gene expression of the androgen repressed rat TR2 orphan receptor: a member of steroid receptor superfamily. Endocrine. 3: 277-83. PMID 21153175 DOI: 10.1007/Bf03021406 |
0.475 |
|
| 2012 |
Yeh C, Chen M, Da J, Messing EM, Vitkus S, Yeh S. 1584 REDUCED PROSTATE BRANCHING MORPHOGENESIS IN STROMAL FIBROBLAST ESTROGEN RECEPTOR α KNOCKOUT, BUT NOT IN EPITHELIAL ESTROGEN RECEPTOR α KNOCKOUT MICE Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1356 |
0.467 |
|
| 2012 |
Yeh C, Chen M, Chang H, Vitkus S, Wen X, Bhowmick N, Wolfe A, Messing EM, Yeh S. 1583 LOSS OF EPITHELIAL OESTROGEN RECEPTOR α INHIBITS OESTROGEN-STIMULATED PROSTATE PROLIFERATION AND SQUAMOUS METAPLASIA VIA IN VIVO TISSUE SELECTIVE KNOCKOUT MODELS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1355 |
0.543 |
|
| 2012 |
Yamashita S, Lai K, Chuang K, Miyamoto H, Tochigi T, Pang S, Li L, Arai Y, Kung H, Yeh S, Chang C. 960 ASC-J9® SUPPRESSES CASTRATION-RESISTANT PROSTATE CANCER GROWTH VIA DEGRADATION OF FULL-LENGTH AND SPLICE VARIANT ANDROGEN RECEPTORS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1059 |
0.52 |
|
| 2011 |
Lin TH, Yeh S, Chang C. Tissue-specific knockout of androgen receptor in mice. Methods in Molecular Biology (Clifton, N.J.). 776: 275-93. PMID 21796532 DOI: 10.1007/978-1-61779-243-4_16 |
0.446 |
|
| 2011 |
Niu Y, Wang J, Shang Z, Huang SP, Shyr CR, Yeh S, Chang C. Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor. Plos One. 6: e20202. PMID 21754978 DOI: 10.1371/Journal.Pone.0020202 |
0.573 |
|
| 2011 |
Yu S, Zhang C, Lin CC, Niu Y, Lai KP, Chang HC, Yeh SD, Chang C, Yeh S. Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. The Prostate. 71: 517-24. PMID 20945497 DOI: 10.1002/Pros.21264 |
0.528 |
|
| 2011 |
Miyamoto H, Yao J, Zheng Y, Hsu I, Izumi K, Netto G, Messing E, Chang C, Yeh S. 522 EXPRESSION OF ANDROGEN AND ESTROGEN RECEPTORS AND ITS PROGNOSTIC SIGNIFICANCE IN HIGH-GRADE UROTHELIAL CARCINOMA OF THE BLADDER Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1218 |
0.395 |
|
| 2010 |
Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Translational Medicine. 2: 32ra35. PMID 20484730 DOI: 10.1126/Scitranslmed.3001143 |
0.346 |
|
| 2010 |
Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene. 29: 3593-604. PMID 20440270 DOI: 10.1038/Onc.2010.121 |
0.565 |
|
| 2010 |
Shyr CR, Tsai MY, Yeh S, Kang HY, Chang YC, Wong PL, Huang CC, Huang KE, Chang C. Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth. The Prostate. 70: 190-9. PMID 19790232 DOI: 10.1002/Pros.21052 |
0.56 |
|
| 2009 |
Nott SL, Huang Y, Li X, Fluharty BR, Qiu X, Welshons WV, Yeh S, Muyan M. Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations. The Journal of Biological Chemistry. 284: 15277-88. PMID 19321454 DOI: 10.1074/Jbc.M900365200 |
0.358 |
|
| 2009 |
Johnykutty S, Tang P, Zhao H, Hicks DG, Yeh S, Wang X. Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 770-5. PMID 19305383 DOI: 10.1038/Modpathol.2009.24 |
0.407 |
|
| 2009 |
Ni J, Mai T, Pang ST, Haque I, Huang K, DiMaggio MA, Xie S, James NS, Kasi D, Chemler SR, Yeh S. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 898-906. PMID 19188160 DOI: 10.1158/1078-0432.Ccr-08-1087 |
0.382 |
|
| 2009 |
Wang RS, Yeh S, Tzeng CR, Chang C. Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocrine Reviews. 30: 119-32. PMID 19176467 DOI: 10.1210/Er.2008-0025 |
0.5 |
|
| 2009 |
Altuwaijri S, Chuang KH, Lai KP, Lai JJ, Lin HY, Young FM, Bottaro A, Tsai MY, Zeng WP, Chang HC, Yeh S, Chang C. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Molecular Endocrinology (Baltimore, Md.). 23: 444-53. PMID 19164450 DOI: 10.1210/Jcem.94.3.9999 |
0.433 |
|
| 2009 |
Chen M, Ni J, Chang HC, Lin CY, Muyan M, Yeh S. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells. Carcinogenesis. 30: 841-50. PMID 19126643 DOI: 10.1093/Carcin/Bgn288 |
0.538 |
|
| 2009 |
Yin Y, Ni J, Chen M, Guo Y, Yeh S. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 190-200. PMID 19118046 DOI: 10.1158/1078-0432.Ccr-08-0910 |
0.416 |
|
| 2009 |
Yu SQ, Lai KP, Xia SJ, Chang HC, Chang C, Yeh S. The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian Journal of Andrology. 11: 39-48. PMID 19098932 DOI: 10.1038/Aja.2008.44 |
0.538 |
|
| 2009 |
Chen M, Wolfe A, Wang X, Chang C, Yeh S, Radovick S. Generation and characterization of a complete null estrogen receptor alpha mouse using Cre/LoxP technology. Molecular and Cellular Biochemistry. 321: 145-53. PMID 18953638 DOI: 10.1007/S11010-008-9928-9 |
0.366 |
|
| 2009 |
Chen M, Hsu I, Wolfe A, Radovick S, Huang K, Yu S, Chang C, Messing EM, Yeh S. Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice. Endocrinology. 150: 251-9. PMID 18755802 DOI: 10.1210/En.2008-0044 |
0.49 |
|
| 2009 |
Niu Y, Yeh S, Chang C. LOSS OF EPITHELIAL ANDROGEN RECEPTOR PROMOTES PROSTATE CANCER PROGRESSION Journal of Urology. 181: 260-260. DOI: 10.1016/S0022-5347(09)60740-0 |
0.559 |
|
| 2008 |
Niu Y, Yeh S, Miyamoto H, Li G, Altuwaijri S, Yuan J, Han R, Ma T, Kuo HC, Chang C. Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation. Cancer Research. 68: 7110-9. PMID 18757426 DOI: 10.1158/0008-5472.Can-07-6507 |
0.567 |
|
| 2008 |
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 105: 12182-7. PMID 18723679 DOI: 10.1073/Pnas.0804700105 |
0.598 |
|
| 2008 |
Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S, Chuang KH, Huang SP, Lardy H, Chang C. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages Proceedings of the National Academy of Sciences of the United States of America. 105: 12188-12193. PMID 18723670 DOI: 10.1073/Pnas.0804701105 |
0.549 |
|
| 2008 |
Ma WL, Ma CL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 135: 947-55, 955.e1-5. PMID 18639551 DOI: 10.1053/J.Gastro.2008.05.046 |
0.396 |
|
| 2008 |
Chen M, Ni J, Zhang Y, Muyan M, Yeh S. ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells. The Prostate. 68: 1273-82. PMID 18563714 DOI: 10.1002/Pros.20774 |
0.544 |
|
| 2008 |
Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology (Baltimore, Md.). 47: 1924-35. PMID 18449947 DOI: 10.1002/Hep.22252 |
0.372 |
|
| 2008 |
Yu IC, Lin HY, Liu NC, Wang RS, Sparks JD, Yeh S, Chang C. Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology. 149: 2361-8. PMID 18276764 DOI: 10.1210/En.2007-0516 |
0.391 |
|
| 2008 |
Yeh S, Ni J, Messing EM, Chemler S, James NS, Chen M, Hsu I. LOW TOXICITY AND HIGH ANTICANCER EFFICACY OF A NOVEL VITAMIN E ETHER ANALOG IN PRECLINICAL PROSTATE CANCER ANIMAL MODELS Journal of Urology. 179: 225-225. DOI: 10.1016/S0022-5347(08)60649-7 |
0.414 |
|
| 2008 |
Niu Y, Han R, Yeh S, Messing EM, Chang C. THE PROSTATIC EPITHELIAL SPECIFIC ANDROGEN RECEPTOR KNOCKOUT TRAMP MICE: AN ANIMAL MODEL FOR ANDROGEN INDEPENDENT PROSTATIC TUMOR Journal of Urology. 179: 188-188. DOI: 10.1016/S0022-5347(08)60546-7 |
0.519 |
|
| 2007 |
Xu Q, Lin HY, Yeh SD, Yu IC, Wang RS, Chen YT, Zhang C, Altuwaijri S, Chen LM, Chuang KH, Chiang HS, Yeh S, Chang C. Infertility with defective spermatogenesis and steroidogenesis in male mice lacking androgen receptor in Leydig cells. Endocrine. 32: 96-106. PMID 17955388 DOI: 10.1007/S12020-007-9015-0 |
0.445 |
|
| 2007 |
Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proceedings of the National Academy of Sciences of the United States of America. 104: 12679-84. PMID 17652515 DOI: 10.1073/Pnas.0704940104 |
0.538 |
|
| 2007 |
Ni J, Yeh S. The roles of alpha-vitamin E and its analogues in prostate cancer. Vitamins and Hormones. 76: 493-518. PMID 17628187 DOI: 10.1016/S0083-6729(07)76019-3 |
0.474 |
|
| 2007 |
Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. Journal of the National Cancer Institute. 99: 558-68. PMID 17406000 DOI: 10.1093/Jnci/Djk113 |
0.492 |
|
| 2007 |
Yin Y, Ni J, Chen M, DiMaggio MA, Guo Y, Yeh S. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2271-80. PMID 17404112 DOI: 10.1158/1078-0432.Ccr-06-1217 |
0.494 |
|
| 2007 |
Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS, Chang C. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nature Medicine. 13: 348-53. PMID 17334372 DOI: 10.1038/Nm1547 |
0.427 |
|
| 2007 |
Ni J, Pang ST, Yeh S. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells. The Prostate. 67: 463-71. PMID 17252538 DOI: 10.1002/Pros.20517 |
0.46 |
|
| 2007 |
Chang E, Ni J, Yin Y, Lin CC, Chang P, James NS, Chemler SR, Yeh S. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells. Asian Journal of Andrology. 9: 31-9. PMID 17187157 DOI: 10.1111/J.1745-7262.2007.00246.X |
0.404 |
|
| 2007 |
Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54. Endocrinology. 148: 1340-9. PMID 17110431 DOI: 10.1210/En.2006-0716 |
0.535 |
|
| 2006 |
Tsai MY, Yeh SD, Wang RS, Yeh S, Zhang C, Lin HY, Tzeng CR, Chang C. Differential effects of spermatogenesis and fertility in mice lacking androgen receptor in individual testis cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 18975-80. PMID 17142319 DOI: 10.1073/Pnas.0608565103 |
0.442 |
|
| 2006 |
Zhang C, Yeh S, Chen YT, Wu CC, Chuang KH, Lin HY, Wang RS, Chang YJ, Mendis-Handagama C, Hu L, Lardy H, Chang C. Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells Proceedings of the National Academy of Sciences of the United States of America. 103: 17718-17723. PMID 17095600 DOI: 10.1073/Pnas.0608556103 |
0.468 |
|
| 2006 |
Wang RS, Yeh S, Chen LM, Lin HY, Zhang C, Ni J, Wu CC, di Sant'Agnese PA, deMesy-Bentley KL, Tzeng CR, Chang C. Androgen receptor in sertoli cell is essential for germ cell nursery and junctional complex formation in mouse testes. Endocrinology. 147: 5624-33. PMID 16973730 DOI: 10.1210/En.2006-0138 |
0.363 |
|
| 2006 |
Ni J, Wen X, Yao JL, Yin Y, Zhang M, Xie S, Chen M, Simons B, Disant'agnese A, Messing EM, Yeh S. 823: Tocopherol Associated Protein Suppresses Prostate Cancer Cell Growth by Inhibition of the PI3 Kinase Pathway Journal of Urology. 175: 265-266. DOI: 10.1016/S0022-5347(18)33059-3 |
0.466 |
|
| 2005 |
Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Research. 65: 9807-16. PMID 16267002 DOI: 10.1158/0008-5472.Can-05-1334 |
0.533 |
|
| 2005 |
Cai G, Huang H, Shapiro E, Zhou H, Yeh S, Melamed J, Greco MA, Lee P. Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate. The Journal of Urology. 173: 2190-2193. PMID 15879885 DOI: 10.1097/01.Ju.0000158119.34126.70 |
0.542 |
|
| 2005 |
Li R, Ni J, Bourne PA, Yeh S, Yao J, di Sant'Agnese PA, Huang J. Cell culture block array for immunocytochemical study of protein expression in cultured cells. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 13: 85-90. PMID 15722799 DOI: 10.1097/00129039-200503000-00014 |
0.325 |
|
| 2005 |
Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Molecular Endocrinology (Baltimore, Md.). 19: 350-61. PMID 15514032 DOI: 10.1210/Me.2004-0190 |
0.467 |
|
| 2004 |
Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine. 25: 27-32. PMID 15545703 DOI: 10.1385/Endo:25:1:27 |
0.354 |
|
| 2004 |
Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY, Chang C. Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 11209-14. PMID 15277682 DOI: 10.1073/Pnas.0404372101 |
0.427 |
|
| 2004 |
Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 279: 33438-46. PMID 15166229 DOI: 10.1074/Jbc.M401781200 |
0.566 |
|
| 2004 |
Chang C, Chen YT, Yeh SD, Xu Q, Wang RS, Guillou F, Lardy H, Yeh S. Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 6876-81. PMID 15107499 DOI: 10.1073/Pnas.0307306101 |
0.46 |
|
| 2004 |
Zhang M, Altuwaijri S, Yeh S. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene. 23: 3080-8. PMID 15048090 DOI: 10.1038/Sj.Onc.1207435 |
0.495 |
|
| 2004 |
Wang L, Hsu CL, Ni J, Wang PH, Yeh S, Keng P, Chang C. Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells. Molecular and Cellular Biology. 24: 2202-13. PMID 14966297 DOI: 10.1128/Mcb.24.5.2202-2213.2004 |
0.568 |
|
| 2004 |
Zhang Y, Yang Y, Yeh S, Chang C. ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation. Molecular and Cellular Biology. 24: 1044-57. PMID 14729952 DOI: 10.1128/Mcb.24.12.5635.2004 |
0.529 |
|
| 2003 |
Yeh S, Hu YC, Wang PH, Xie C, Xu Q, Tsai MY, Dong Z, Wang RS, Lee TH, Chang C. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. The Journal of Experimental Medicine. 198: 1899-908. PMID 14676301 DOI: 10.1084/Jem.20031233 |
0.464 |
|
| 2003 |
Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Research. 63: 7106-12. PMID 14612503 |
0.419 |
|
| 2003 |
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Research. 63: 4888-94. PMID 12941811 |
0.438 |
|
| 2003 |
Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. The Journal of Biological Chemistry. 278: 23691-8. PMID 12714604 DOI: 10.1074/Jbc.M211908200 |
0.348 |
|
| 2003 |
Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C. Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells. The Journal of Biological Chemistry. 278: 19619-26. PMID 12649293 DOI: 10.1074/Jbc.M210941200 |
0.586 |
|
| 2003 |
Ni J, Chen M, Zhang Y, Li R, Huang J, Yeh S. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochemical and Biophysical Research Communications. 300: 357-63. PMID 12504091 DOI: 10.1016/S0006-291X(02)02851-6 |
0.512 |
|
| 2003 |
Tsai M, Yeh S, Yeh S, Xu Q, Chang C. Normal spermatogenesis and fertility in germ cell-specific genomic androgen receptor knockout mice Fertility and Sterility. 80: 277. DOI: 10.1016/S0015-0282(03)01704-7 |
0.41 |
|
| 2002 |
Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, et al. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proceedings of the National Academy of Sciences of the United States of America. 99: 13498-503. PMID 12370412 DOI: 10.1073/Pnas.212474399 |
0.344 |
|
| 2002 |
Thin TH, Kim E, Yeh S, Sampson ER, Chen YT, Collins LL, Basavappa R, Chang C. Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation. The Journal of Biological Chemistry. 277: 36499-508. PMID 12068007 DOI: 10.1074/Jbc.M202824200 |
0.446 |
|
| 2002 |
Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 7408-13. PMID 12032296 DOI: 10.1073/Pnas.102014399 |
0.573 |
|
| 2002 |
Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C. Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator. The Journal of Biological Chemistry. 277: 15426-31. PMID 11856738 DOI: 10.1074/Jbc.M111218200 |
0.503 |
|
| 2002 |
Ting HJ, Yeh S, Nishimura K, Chang C. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America. 99: 661-6. PMID 11792840 DOI: 10.1073/Pnas.022469899 |
0.478 |
|
| 2002 |
Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth. The Journal of Biological Chemistry. 277: 4609-17. PMID 11673464 DOI: 10.1074/Jbc.M108312200 |
0.591 |
|
| 2001 |
Wang X, Yeh S, Wu G, Hsu CL, Wang L, Chiang T, Yang Y, Guo Y, Chang C. Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells. The Journal of Biological Chemistry. 276: 40417-23. PMID 11509567 DOI: 10.1074/Jbc.M104765200 |
0.435 |
|
| 2001 |
Lin HK, Yeh S, Kang HY, Chang C. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proceedings of the National Academy of Sciences of the United States of America. 98: 7200-5. PMID 11404460 DOI: 10.1073/Pnas.121173298 |
0.444 |
|
| 2001 |
Kang HY, Lin HK, Hu YC, Yeh S, Huang KE, Chang C. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 98: 3018-23. PMID 11248024 DOI: 10.1073/Pnas.061305498 |
0.478 |
|
| 2000 |
Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 97: 11256-61. PMID 11016951 DOI: 10.1073/Pnas.190353897 |
0.567 |
|
| 1999 |
Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine. 11: 195-202. PMID 10709768 DOI: 10.1385/Endo:11:2:195 |
0.576 |
|
| 1999 |
Chang HC, Miyamoto H, Marwah P, Lardy H, Yeh S, Huang KE, Chang C. Suppression of Δ5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells Proceedings of the National Academy of Sciences of the United States of America. 96: 11173-11177. PMID 10500149 DOI: 10.1073/Pnas.96.20.11173 |
0.497 |
|
| 1999 |
Yeh S, Chang HC, Miyamoto H, Takatera H, Rahman M, Kang HY, Thin TH, Lin HK, Chang C. Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators. The Keio Journal of Medicine. 48: 87-92. PMID 10405524 DOI: 10.2302/Kjm.48.87 |
0.569 |
|
| 1999 |
Heinlein CA, Ting HJ, Yeh S, Chang C. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. The Journal of Biological Chemistry. 274: 16147-52. PMID 10347167 DOI: 10.1074/Jbc.274.23.16147 |
0.383 |
|
| 1999 |
Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 96: 5458-63. PMID 10318905 DOI: 10.1073/Pnas.96.10.5458 |
0.533 |
|
| 1999 |
Kang H, Yeh S, Fujimoto N, Chang C. Cloning and Characterization of Human Prostate Coactivator ARA54, a Novel Protein That Associates with the Androgen Receptor Journal of Biological Chemistry. 274: 8570-8576. PMID 10085091 DOI: 10.1074/Jbc.274.13.8570 |
0.555 |
|
| 1999 |
Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, Mizokami A, Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. The Journal of Biological Chemistry. 274: 8316-21. PMID 10075738 DOI: 10.1074/Jbc.274.12.8316 |
0.556 |
|
| 1999 |
Fujimoto N, Matsumoto T, Inui S, Yeh S, Kang H, Chang C. Cloning And Characterization Of Novel Androgen Receptor Associated Protein Ara55 The Journal of Urology. 54. DOI: 10.1097/00005392-199904010-00217 |
0.384 |
|
| 1998 |
Miyamoto H, Yeh S, Lardy H, Messing E, Chang C. δ5-Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells Proceedings of the National Academy of Sciences of the United States of America. 95: 11083-11088. PMID 9736693 DOI: 10.1073/Pnas.95.19.11083 |
0.548 |
|
| 1998 |
Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, Chang C. Retinoblastoma, a Tumor Suppressor, Is a Coactivator for the Androgen Receptor in Human Prostate Cancer DU145 Cells☆ Biochemical and Biophysical Research Communications. 248: 361-367. PMID 9675141 DOI: 10.1006/Bbrc.1998.8974 |
0.557 |
|
| 1998 |
Miyamoto H, Yeh S, Wilding G, Chang C. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells Proceedings of the National Academy of Sciences of the United States of America. 95: 7379-7384. PMID 9636157 DOI: 10.1073/Pnas.95.13.7379 |
0.561 |
|
| 1998 |
Yeh S, Miyamoto H, Shima H, Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proceedings of the National Academy of Sciences of the United States of America. 95: 5527-5532. PMID 9576916 DOI: 10.1073/Pnas.95.10.5527 |
0.539 |
|
| 1997 |
Yeh S, Miyamoto H, Chang C. Hydroxyflutamide may not always be a pure antiandrogen. Lancet (London, England). 349: 852-3. PMID 9121269 DOI: 10.1016/S0140-6736(05)61756-4 |
0.383 |
|
| 1996 |
Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells Proceedings of the National Academy of Sciences of the United States of America. 93: 5517-5521. PMID 8643607 DOI: 10.1073/Pnas.93.11.5517 |
0.579 |
|
| 1995 |
Chang C, Saltzman A, Yeh S, Young W, Keller ET, Lee H, Wang C, Mizokami A. Androgen receptor: an overview. Critical Reviews in Eukaryotic Gene Expression. 5: 97-125. PMID 8845584 DOI: 10.1615/Critreveukargeneexpr.V5.I2.10 |
0.463 |
|
| 1994 |
Mizokami A, Yeh S, Chang C. Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Molecular Endocrinology. 8: 77-88. PMID 8152432 DOI: 10.1210/Mend.8.1.8152432 |
0.405 |
|
| 1994 |
Chang C, Da Silva SL, Ideta R, Lee Y, Yeh S, Burbach JP. Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily. Proceedings of the National Academy of Sciences of the United States of America. 91: 6040-4. PMID 8016112 DOI: 10.1073/Pnas.91.13.6040 |
0.383 |
|
| Show low-probability matches. |